Click HERE to read a paper about the results in Cardiovascular News

Brief summary

Activation is a prospective randomised (1 :1) controlled study to test the hypothesis that revascularisation of significant coronary artery disease by Percutaneous Coronary Intervention prior to Transcatheter Aortic Valve Implantation (TAVI) will result in rate of mortality and re-hospitalisation at 12 months that is non-inferior to TAVI without such revascularisation.

Primary endpoints

Composite of mortality and rehospitalisation at 12 months

CERC Services

Clinical trial documentation,

Regulatory submissions,

Set-up activities,

eCRF / data-management,

Monitoring,

CEC,

DSMB,

Clinical report

Countries

France, Germany, United Kingdom

Centers number

17 investigational centers